Patient interface

Information

  • Patent Grant
  • 9421339
  • Patent Number
    9,421,339
  • Date Filed
    Friday, January 24, 2014
    10 years ago
  • Date Issued
    Tuesday, August 23, 2016
    8 years ago
Abstract
A patient interface for use with the administration of CPAP therapy to a patient, comprising: a body for connection with a supply of pressurized breathable gas pressurized above ambient; and a compliant patient contacting element to communicate the pressurized gas to at least the patient's nasal passages, the element including a multilayered cushioning interface, the interface comprising an interior layer and an exterior layer being provided in spaced relation to the interior layer, the exterior layer being elastically and resiliently movable towards and away the interior layer in use. Along at least a portion of the perimeter of the exterior layer, a surface of the exterior layer is deformable from the spaced relation to abut against and contact against a surface of the interior layer in dependence at least in part on a deformation force applied to the exterior layer.
Description
FIELD OF THE INVENTION

The invention relates generally to a nasal mask and to a cushion therefor, for example, for use in the treatment of respiratory conditions and in assisted respiration.


BACKGROUND OF THE INVENTION

Nasal masks are commonly used in the treatment of respiratory conditions and sleep disorders (e.g., obstructive sleep apnea) by delivering a flow of breathable gas for, or to assist patient respiration. These nasal masks typically receive a gas supply line which delivers gas into a chamber formed by walls of the mask. The walls usually are semi-rigid and have a face contacting portion including an aperture which is aligned with the wearer's nostrils. The face contacting portion can comprise a soft, resilient elastomeric material which may conform to various facial contours. The mask normally is secured to the wearer's head by straps. The straps are adjusted to pull the mask against the face with sufficient force to achieve a gas tight seal between the mask and the wearer's face. Gas is thus delivered to the mask and through the aperture to the wearer's nasal passages.


Problems often arise with masks of the above configuration. For example, the mask may be dislodged, thereby breaking the seal between the mask and wearer. This may occur if the wearer rolls over when sleeping thereby creating a drag force on the gas supply line which is transmitted to the mask, breaking the seal. In the case of a mask being used for the administration of Continuous Positive Airway Pressure (CPAP) treatment for the condition obstructive sleep apnea, such a leak can result in the pressure supplied to the entrance of the wearer's airway being below the therapeutic value, and the treatment becoming ineffective.


Another problem is that the face contacting portion may apply excessive pressure to the wearer's face resulting in discomfort and possibly skin irritation. This excessive forces. In some cases these excessive pressures and forces may cause the face to distort to conform with the face contacting portion to increase wearer discomfort, facial soreness and ulceration.


Other types of devices exist whereby small nostril nosepieces (pillows) are held in place by a harness strapped over the wearer's head, for example as shown in prior art U.S. Pat. No. 4,782,832. While this arrangement may alleviate some problems regarding seal breakage and skin abrasion, the harnesses associated with such devices are quite cumbersome for the wearer, as are the gas supply lines. Also, air ‘jetting’ into the nostrils can be irritating to the patient making such devices generally uncomfortable to use.


In FIGS. 1-3, a prior art nasal cushion 10, generally equivalent to that shown in prior art U.S. Pat. No. 5,243,971, is first described.


As shown, the cushion 10 generally includes a base 11 from which depends a semi-rigid cushion frame 12 formed of elastomeric material. Attached over the outside of the frame 12 is a membrane 15, also of elastomeric material, having at its distal end a face contacting portion 14. The frame 12 and the membrane 15 generally form a chamber 17 into which the wearer's nose can be received. The frame 12 has a notch 19 to accommodate the bridge of the wearer's nose. The base 11 includes slots 13 to accommodate straps (not shown) to secure the cushion 10 and a mask body (not shown) in combination to the wearer's head.


An aperture 16 is formed at the end of the membrane 15 distal from the frame 12 providing access for a wearer's nose 20 to the chamber 17 as noted. As shown, the aperture 16 in an unflexed state is generally circular (or elliptical) and is large enough to allow partial entry of the wearer's nose. The resilience of the membrane material allows the face contacting portion 14 and the aperture 16 to invert when the nose is received. The inverted membrane arrangement relies upon a positive pressure of supplied gas within the mask to effect a seal to the wearer's face. The seal is characterised as a “rolling edge seal”, in that there can be motion of the cushion 10 relative to the patient's face yet the seal is maintained. Even so, a tuck 22 arises in the vicinity of the upper lip due to the circular shape of the aperture, and it is from this tuck that leaks can arise due to head and body movement during sleep.


It is an object of the invention to overcome or at least substantially ameliorate one or more of the foregoing disadvantages.


SUMMARY OF THE INVENTION

In one broad form, the invention discloses a nasal mask cushion to sealingly connect a mask to a wearer's face, the cushion comprising:

    • a substantially triangularly-shaped frame of resilient material having a rim to surround the wearer's nose;
    • a membrane also of resilient material, the membrane being relatively more flexible than the frame, and being of the same general shape as said rim and fixed to and extending away from the frame so as to have an outer surface spaced from the rim, a portion of said outer surface forming a face contacting seal; and
    • a nose-receiving cavity bounded by said frame and said membrane;
    • and wherein said seal portion is generally coterminous with respect to said rim and is resiliently deformable towards the rim in use of the cushion.


Preferably, the rim and seal portion are shaped to generally match facial contours of the facial tissue around the sides and over the bridge of the nose and between the base of the nose and the top lip.


In one particularly advantageous form, the membrane is substantially saddle-shaped. The membrane further has a centrally located aperture through which the wearer's nose passes to enter said cavity.


It is preferred that the cushion and membrane each include a co-located notch to accommodate the bridge of the nose of the wearer. Typically, the seal portion contacts at least the wearer's nose, and preferably, also the facial tissue around the sides and over the bridge of the nose and between the base of the nose and the top lip.


The invention further discloses a nasal mask for connection to a wearer's face comprising:


a mask body for connection with a supply of breathable gas; and


a nasal cushion, the body and cushion defining a nose-receiving cavity, the cushion including:


a substantially triangularly-shaped frame of resilient material having a rim to surround the wearer's nose;


a membrane also of resilient material, the membrane being relatively more flexible than the frame, and being of the same general shape as said rim and fixed to and extending away from the frame so as to have an outer surface spaced from the frame, a portion of said outer surface forming a face contacting seal;


and wherein said seal portion is generally coterminous with respect to said rim and is resiliently deformable towards the rim in use of the mask.


The mask body can further include attachment points from which securing straps can be attached, and by which the mask can be secured to the wearer's head. The nasal mask can yet further comprise an arm depending from said body from which a further securing strap(s) can be attached.


The invention further discloses nasal CPAP treatment apparatus comprising a flow generator for the supply of gas at a pressure elevated above atmospheric pressure to a gas delivery conduit, the conduit in turn coupled to a nasal mask as described immediately above.


In one particularly preferred form, a supply of gas can be provided to said cavity, said supply of gas assisting, but not solely causing maintenance of a seal by said seal forming portion of said membrane to the face of the wearer in use of the cushion.


Advantageously, because the membrane and the rim are substantially shaped to the facial contour, and the membrane does not need to turn in on itself, as in the prior art, thus contacting the face without folds or creases. With the cushion/mask secured to the wearer's head, the headstraps need only to be tensioned to balance the force due to mask gas pressure that tends to lift the mask off the face. Such relatively lower mask-to-face pressure results in greater patient comfort, and a reduction in the likelihood of skin irritation.





BRIEF DESCRIPTION OF THE DRAWINGS

An embodiment of the invention will now be described with reference to the accompanying drawings, in which;



FIG. 1 is an exploded perspective view of a prior art nasal mask;



FIG. 2 is a perspective view of the prior art nasal mask of FIG. 1;



FIG. 3 is a perspective view of the prior art nasal mask attached to a wearer;



FIG. 4 is a rear perspective view of a mask cushion embodying the present invention;



FIG. 5 is a cross-sectional view along line 5-5;



FIG. 6 is a perspective view of a nasal mask including the cushion of FIGS. 4 and 5; and



FIG. 7 is a perspective view of the nasal mask of FIG. 6 secured to a wearer's head.





DESCRIPTION OF THE PREFERRED EMBODIMENTS


FIG. 4 shows a perspective view of a nasal cushion 30 embodying the invention. FIG. 5 shows the cross-sectional view along line 5-5. The cushion 30 comprises a substantially triangularly shaped frame 32 from which extends a membrane 34. The frame 32 has a scalloped edge 36 by which the cushion 30 is affixed to a mask body, as presently will be described.


The membrane 34 has an aperture 38 into which the wearer's nose is received in use of the cushion 30. The membrane 34 is spaced away from the rim 40 of the frame 32, and its outer surface 41 is of substantially the same shape as the rim 40. The outer surface 41 of the membrane 34 and the rim 40 of the frame 32 also can be described as generally saddle shaped. The shaping of the outer surface 41 of the membrane 34 and the rim 40 of the frame 32 also include respective notches 42, 44 that receive the bridge of the wearer's nose in use of the cushion 30.


As is best seen in FIG. 5, the frame 32 and the membrane 34 are integrally formed, typically by in a one-shot molding process. The frame 32 and the membrane 34 are fabricated from a resilient material. One suitable such material is Silastic™ silicone elastomer manufactured by Dow Corning. The frame 32, in one preferred embodiment, has a typical thickness at its rim 40 of 1.5 mm. The membrane 34, in a preferred embodiment, has a typical thickness of 0.35 mm. In this way, the membrane 34 is relatively more flexible than the rim 40.


In use of the cushion 30, a wearer's nose will be inserted in the aperture 38 to engage a seal forming portion 45 (formed between the dashed lines) of the outer surface 41 to cause deformation of the membrane 34. Depending upon the securing force supplied to the membrane 34, it may deform to a point where it butts against the rim 40 of the frame 32. The frame 32 has a rigidity sufficient to withstand usual securing pressures in use of the cushion 30 to tend to retain its shape and resist deformation. It thus acts as a supporting structure.


Referring now to FIG. 6, the nasal cushion 30 is shown attached to a mask body 46 by the edge 36 of the frame 32, adhered or otherwise secured to a flange 48 of 20 the mask body 46. Only the outer surface 41 of the membrane 34 can be seen. The flange 48 includes three slots 50, 52, 54 from which tensioning straps can be attached to secure the cushion 30 and the mask body 46 (in combination) to the head of a wearer.


The mask body 46 forms a cavity that can receive the nose of the wearer by the aperture 38. A port 56 is provided at the top of the mask body 46 by which breathable gas can be supplied to the chamber.


Referring now to FIG. 7, there is shown a nasal mask 60 including the mask body 46 and the mask cushion 30. A coupling tube 62 is connected at one end with the inlet port 56, and at the other to a socket 64 into which can be received a gas delivery tube (not shown) for the supply of breathable gas to the chamber internal of the mask body 46. The mask body 46 also has two vent openings 66 by which expired gas is exhausted. A first fastening strap 68 is fixed between to the lower two slots 50, 54. The upper slot 52 receives an arm 70, the top end of which has a resilient pad 72 to engage the forehead of the wearer. The arm 70 has two slots 74, 76 along its side edges, by which a second fastening strap 78 is secured.


In fitting the nasal mask 60, the wearer's nose is received through the aperture 38 into the chamber within the mask body 46. The seal forming portion 45 thus contacts both the surface of the wearer's nose and a portion of the wearer's face in the region between the base of the nose and the upper lip, and around the sides and over the bridge of the nose. The shape of the seal forming portion 45 is particularly suited to effectively seal the difficult region of the facial contour that is the crease between the sides of the nose and the face. Depending upon the tension applied by the fastening straps 68,78, a seal is formed with the membrane 34 remaining spaced from the rim 40 of the cushion frame 32. While the provision of pressurised gas to the chamber of the mask body 46 assists in the maintenance of a seal between the membrane 34 and the wearer's nose and face, it is not essential in most cases, and an effective seal will be formed absent any such pressurised gas. The seal formed between the membrane 34 and the wearer's nose and face is not in the nature of a rolling seal in the manner of prior art as shown in FIGS. 1 to 3, as on relative movement of the mask 60 in relation to the wearer's head, the nose will be restrained by contacting the frame 32. Thus only limited relative motion between the mask 60 and the wearer's nose and face occurs.


The membrane 34 closely imitates the facial contour, and because of its relatively lesser stiffness than the frame 32, can conform to particular facial structures with minimum force, and without a tendency to fold or crease.


If the fastening strap 68, 78 are tensioned to excess, the membrane 34 deforms to abut the rim 40 of the cushion 32, the frame 32 thus acting as an “end limit”. In such a configuration, almost zero relative movement can occur between the mask 60 and the wearer's head.


The nasal cushion 30 and nasal mask 60 has been described with reference to CPAP or assisted respiration treatment, however it is to be understood that the invention generally is applicable to any application where gas and/or atomised liquid is to be supplied to the entrance of the nasal airways. Such applications include nebulisers, gas masks and anaesthetic machines.

Claims
  • 1. A patient interface for treatment of sleep apnea, comprising: a body for connection with a supply of pressurized breathable gas under continuous positive airway pressure; anda compliant cushion of silicone elastomer defining at least a portion of a breathing chamber configured to communicate the pressurized gas to a patient's nasal passages, said cushion including:a frame, said frame being of resilient material and having a first membrane, the first membrane extending along at least a portion of an inner perimeter of the frame, said frame having a front portion with an edge structured to be coupled to the body; anda second membrane of resilient material, said second membrane spaced an open distance from said first membrane along substantially an entire length of the second membrane when the patient interface is not in use, a portion of said second membrane forming a face contacting seal, wherein a substantially full perimeter of the second membrane is provided in covering yet spaced relation to the first membrane,wherein along at least a portion of the perimeter of the second membrane, a surface of the second membrane is deformable from said spaced distance to abut against and contact a surface of the first membrane in dependence at least in part on a deformation force applied to the second membrane, andwherein the first and second membranes are formed as a one-piece unit andwherein said first and second membranes are turned inwards relative to the frame along substantially the full perimeter of the frame.
  • 2. The patient interface according to claim 1, wherein said distance is greater than a thickness of the first membrane, said distance measured when the patient interface is not in use.
  • 3. The patient interface of claim 1, wherein the second membrane is conformable, in use, to various facial structures that contribute to the deformation force applied to the second membrane.
  • 4. The patient interface of claim 3, wherein a first deformation position of the second membrane is defined by the first membrane.
  • 5. The patient interface of claim 4, wherein the first deformation position is not reached depending on the deformation force.
  • 6. The patient interface of claim 1, wherein the first membrane is thicker than the second membrane.
  • 7. The patient interface of claim 6, wherein the first membrane is about four times as thick as the second membrane.
  • 8. The patient interface of claim 1, wherein the first and second membranes have substantially the same shape.
  • 9. The patient interface according to claim 1, wherein the patient interface further comprises at least one headgear strap, and the deformation force depends at least in part on strap tension applied to the strap.
  • 10. The patient interface of claim 1, wherein the first and second membranes are spaced from one another and do not contact one another when the patient interface is not in use.
  • 11. The patient interface of claim 1, wherein an outer surface of the second membrane is of substantially the same shape as the first membrane, wherein the second membrane and face contacting seal portion are shaped to generally match facial contours of the facial tissue around the sides and over the bridge of the nose and between the base of the nose and the top lip; andfurther wherein the shaping of the outer surface of the second membrane and the first membrane are preformed to receive the bridge of the wearer's nose in use of the patient interface.
  • 12. The patient interface of claim 1, wherein only the second membrane forms a face contacting seal with the patient in use.
  • 13. The patient interface of claim 1, wherein the first membrane does not include a face contacting seal.
  • 14. A patient interface for treatment of sleep apnea, comprising: a body for connection with a supply of pressurized breathable gas under continuous positive airway pressure; anda compliant cushion defining at least a portion of a breathing chamber configured to communicate the pressurized gas to a patient's nasal passages, said cushion having a front portion with an edge structured to be coupled to the body, said cushion including: a first membrane made of molded resilient material, anda second membrane of molded resilient material, said second membrane spaced an open distance from said first membrane along substantially an entire length of the second membrane when the patient interface is not in use, a portion of said second membrane forming a face contacting seal, wherein a substantially full perimeter of the second membrane is turned inwardly and provided in covering yet spaced relation to the first membrane,wherein along at least a portion of the perimeter of the second membrane, a surface of the second membrane is deformable from said spaced distance to abut against and contact a surface of the first membrane in dependence at least in part on a deformation force applied to the second membrane, andwherein the first and second membranes are formed as a one-piece unit.
  • 15. The patient interface according to claim 14, wherein said distance is greater than a thickness of the first membrane, said distance measured when the patient interface is not in use.
  • 16. The patient interface of claim 14, wherein the second membrane is conformable, in use, to various facial structures that contribute to the deformation forces applied to the second membrane.
  • 17. The patient interface of claim 16, wherein a first deformation position of the second membrane is defined by the first membrane.
  • 18. The patient interface of claim 17, wherein the first deformation position is not reached depending on the deformation force.
  • 19. The patient interface of claim 14, wherein the first membrane is thicker than the second membrane.
  • 20. The patient interface of claim 14, wherein the first and second membranes have substantially the same shape.
  • 21. The patient interface of claim 14, wherein the body includes at least one vent opening.
  • 22. The patient interface of claim 14, further comprising headgear and the body includes one or more structures to fasten a headgear strap.
  • 23. The patient interface according to claim 14, wherein the patient interface further comprises at least one headgear strap, and the deformation force depends at least in part on strap tension applied to the strap.
  • 24. The patient interface according to claim 14, wherein the first and second membranes are spaced from one another and do not contact one another when the patient interface is not in use.
  • 25. The patient interface of claim 14, wherein an outer surface of the second membrane is of substantially the same shape as the first membrane, wherein the second membrane and face contacting seal portion are shaped to generally match facial contours of the facial tissue around the sides and over the bridge of the nose and between the base of the nose and the top lip; andfurther wherein the shaping of an outer surface of the second membrane and the first membrane are pre-shaped and receive the bridge of the wearer's nose in use of the patient interface.
  • 26. The patient interface of claim 14, wherein only the second membrane forms a face contacting seal with the patient in use.
  • 27. The patient interface of claim 14, wherein the first membrane does not include a face contacting seal.
  • 28. A patient interface for use with the administration of CPAP therapy to a patient, comprising: a body for connection with a supply of pressurized breathable gas pressurized above ambient; anda compliant patient contacting element configured to communicate the pressurized gas to at least the patient's nasal passages, said element including a multilayered cushioning interface, said interface comprising an interior layer and an exterior layer having substantially an entire length provided in spaced relation to the interior layer when the patient interface is not in use, said exterior layer being elastically and resiliently movable towards and away the interior layer in use, only said exterior layer forming a contacting seal with the patient in use,wherein along at least a portion of a perimeter of the exterior layer, a surface of the exterior layer is deformable from said spaced relation to abut against and contact against a surface of the interior layer in dependence at least in part on a deformation force applied to the exterior layer.
  • 29. The patient interface according to claim 28, wherein the face contacting seal is provided only to the exterior layer, while the interior layer includes no face contacting seal, wherein the interior and exterior layers are formed as a one piece unit.
  • 30. The patient interface according to claim 28, wherein the face contacting seal is provided only to the exterior layer, while the interior layer includes no face contacting seal.
  • 31. The patient interface according to claim 28, wherein said exterior layer is preformed to match the general shape of a portion of the patient's face in use.
  • 32. The patient interface according to claim 28, wherein the patient interface further comprises at least one headgear strap, and the deformation force depends at least in part on strap tension applied to the strap.
  • 33. The patient interface of claim 28, wherein the interior and exterior layers are spaced from one another and do not contact one another when the patient interface is not in use.
  • 34. The patient interface of claim 28, wherein the interior layer is of substantially the same shape as the exterior layer.
  • 35. The patient interface of claim 28, wherein the exterior layer is turned inwards along an entire perimeter of the exterior layer.
Priority Claims (1)
Number Date Country Kind
PO1265 Jul 1996 AU national
Parent Case Info

This application is a continuation of U.S. application Ser. No. 11/648,537, filed Jan. 3, 2007, now U.S. Pat. No. 8,636,006, which is a continuation of U.S. application Ser. No. 10/068,963, filed Feb. 11, 2002, now U.S. Pat. No. 7,178,527, which is a continuation of U.S. application Ser. No. 09/230,491, filed Aug. 11, 1999, now U.S. Pat. No. 6,357,441, which claims the benefit of Australian Patent Application No. PO1265, filed Jul. 26, 1996, and is the U.S. National Stage of PCT Application No. PCT/AU97/00450, filed Jul. 16, 1997 (published as WO 98/04310 on Feb. 5, 1998), each incorporated by reference in its entirety. This application contains subject matter related to U.S. application Ser. No. 08/791,212, filed Jan. 31, 1997, now U.S. Pat. No. 6,112,746, which also claims priority to Australian Provisional Patent Application No. PO 1265, filed Jul. 26, 1996, each incorporated by reference in its entirety.

US Referenced Citations (212)
Number Name Date Kind
781515 Guthrie Jan 1905 A
812706 Warbasse Feb 1906 A
902961 Goodnow Nov 1908 A
1000706 Barnum Aug 1911 A
1081745 Johnston et al. Dec 1913 A
1105127 Drager Jul 1914 A
1192186 Greene Jul 1916 A
1206045 Smith Nov 1916 A
1632449 McKesson Jun 1927 A
1653572 Jackson Dec 1927 A
1926027 Biggs Sep 1933 A
1975797 Montuori Oct 1934 A
2123353 Catt Jul 1938 A
2166164 Lemberg Jul 1939 A
2248477 Lombard Jul 1941 A
2254854 O'Connell Sep 1941 A
2317608 Heidbrink Apr 1943 A
2371965 Lehmberg Mar 1945 A
2376871 Fink May 1945 A
2387522 Maurer Oct 1945 A
2415846 Randall Feb 1947 A
2438058 Kincheloe Mar 1948 A
2465973 Bulbulian Mar 1949 A
2578621 Yant Dec 1951 A
2625155 Engelder Jan 1953 A
2875757 Galleher, Jr. Jan 1954 A
2931356 Schwarz Apr 1960 A
D188084 Garelick May 1960 S
2936458 Luisada May 1960 A
2939458 Lundquist Jun 1960 A
3013556 Galleher Dec 1961 A
3044464 Gray Jul 1962 A
3182659 Blount et al. May 1965 A
3189027 Bartlett Jun 1965 A
3193624 Webb et al. Jul 1965 A
3227159 Borgia et al. Jan 1966 A
3238943 Holley Mar 1966 A
3315674 Bloom et al. Apr 1967 A
3330273 Bennett Jul 1967 A
3330274 Bennett Jul 1967 A
3362420 Blackburn et al. Jan 1968 A
3363833 Laerdal Jan 1968 A
3521630 Westberg et al. Jul 1970 A
3556122 Laerdal Jan 1971 A
3580051 Blevins May 1971 A
3680555 Warncke Aug 1972 A
3700000 Hesse et al. Oct 1972 A
3720235 Schrock Mar 1973 A
3725953 Johnson et al. Apr 1973 A
3796216 Schwarz Mar 1974 A
3799164 Rollins Mar 1974 A
D231803 Huddy Jun 1974 S
4015598 Brown Apr 1977 A
4077404 Elam Mar 1978 A
D250131 Lewis et al. Oct 1978 S
4167185 Lewis Sep 1979 A
4174710 Pampuch Nov 1979 A
4226234 Gunderson Oct 1980 A
4245632 Houston Jan 1981 A
D262322 Mizerak Dec 1981 S
4304229 Curtin Dec 1981 A
4305387 Reist-Kundig et al. Dec 1981 A
4328797 Rollins et al. May 1982 A
4347205 Stewart Aug 1982 A
4354488 Bartos Oct 1982 A
4402316 Gadberry Sep 1983 A
4412537 Tiger Nov 1983 A
4414973 Matheson et al. Nov 1983 A
4454880 Muto et al. Jun 1984 A
4467799 Steinberg Aug 1984 A
4522639 Ansite et al. Jun 1985 A
4558710 Eichler Dec 1985 A
4574799 Warncke Mar 1986 A
4616647 McCreadie Oct 1986 A
4622964 Flynn Nov 1986 A
4655213 Rapoport et al. Apr 1987 A
4665570 Davis May 1987 A
4671271 Bishop et al. Jun 1987 A
4677975 Edgar et al. Jul 1987 A
4677977 Wilcox Jul 1987 A
4689837 Bolle Sep 1987 A
H397 Stark Jan 1988 H
D293613 Wingler Jan 1988 S
4739755 White et al. Apr 1988 A
4770169 Schmoegner et al. Sep 1988 A
4774941 Cook Oct 1988 A
4782832 Trimble et al. Nov 1988 A
4794921 Lindkvist Jan 1989 A
4799477 Lewis Jan 1989 A
4803981 Vickery Feb 1989 A
4809692 Nowacki et al. Mar 1989 A
4811730 Milano Mar 1989 A
4819629 Jonson Apr 1989 A
4821713 Bauman Apr 1989 A
4841953 Dodrill Jun 1989 A
4848334 Bellm Jul 1989 A
4848366 Aite et al. Jul 1989 A
4907584 McGinnis Mar 1990 A
4910806 Baker et al. Mar 1990 A
4919128 Kopala et al. Apr 1990 A
4922921 Donoghue May 1990 A
4938210 Shene Jul 1990 A
4938212 Gnook et al. Jul 1990 A
4944310 Sullivan Jul 1990 A
D310431 Bellm Sep 1990 S
4971051 Toffolon Nov 1990 A
4986269 Hakkinen Jan 1991 A
4989596 Macris et al. Feb 1991 A
4989599 Carter Feb 1991 A
5003633 Itoh Apr 1991 A
5005568 Loescher et al. Apr 1991 A
5005571 Dietz Apr 1991 A
5038776 Harrison et al. Aug 1991 A
5042473 Lewis Aug 1991 A
5042478 Kopala et al. Aug 1991 A
5046200 Feder Sep 1991 A
5063922 Hakkinen Nov 1991 A
5065756 Rapoport Nov 1991 A
5069205 Urso Dec 1991 A
D323908 Hollister et al. Feb 1992 S
5109839 Blasdell et al. May 1992 A
5109840 Daleiden May 1992 A
5121745 Israel Jun 1992 A
5133347 Huennebeck Jul 1992 A
5140980 Haughey et al. Aug 1992 A
5140982 Bauman Aug 1992 A
5148802 Sanders et al. Sep 1992 A
5159938 Laughlin Nov 1992 A
5178138 Walstrom et al. Jan 1993 A
D334633 Rudolph Apr 1993 S
5220699 Farris Jun 1993 A
5231983 Matson et al. Aug 1993 A
5233978 Callaway Aug 1993 A
5243971 Sullivan et al. Sep 1993 A
5265595 Rudolph Nov 1993 A
5279289 Kirk Jan 1994 A
5280784 Kohler Jan 1994 A
5297544 May et al. Mar 1994 A
5297547 Brain Mar 1994 A
5311862 Blasdell et al. May 1994 A
5322057 Raabe et al. Jun 1994 A
5322059 Walther Jun 1994 A
5323774 Fehlauer Jun 1994 A
5343878 Scarberry et al. Sep 1994 A
5349949 Schegerin Sep 1994 A
5357951 Ratner Oct 1994 A
5372130 Stern et al. Dec 1994 A
5388571 Roberts et al. Feb 1995 A
5404871 Goodman et al. Apr 1995 A
5419318 Tayebi May 1995 A
5429126 Bracken Jul 1995 A
5429683 Le Mitouard Jul 1995 A
5431158 Tirotta Jul 1995 A
5438981 Starr et al. Aug 1995 A
5441046 Starr et al. Aug 1995 A
D362061 McGinnis et al. Sep 1995 S
5477852 Landis et al. Dec 1995 A
5479920 Piper et al. Jan 1996 A
5488948 Dubruille et al. Feb 1996 A
5492116 Scarberry et al. Feb 1996 A
5501214 Sabo Mar 1996 A
5509404 Lloyd et al. Apr 1996 A
5517986 Starr et al. May 1996 A
5538000 Rudolph Jul 1996 A
5540223 Starr et al. Jul 1996 A
5542128 Lomas Aug 1996 A
5546936 Virag et al. Aug 1996 A
RE35339 Rapoport Oct 1996 E
5560354 Berthon-Jones et al. Oct 1996 A
5570682 Johnson Nov 1996 A
5570689 Starr et al. Nov 1996 A
D377089 Starr et al. Dec 1996 S
5592938 Scarberry et al. Jan 1997 A
5608647 Rubsamen et al. Mar 1997 A
5642730 Baran Jul 1997 A
5647355 Starr et al. Jul 1997 A
5647357 Barnett et al. Jul 1997 A
5649532 Griffiths Jul 1997 A
5649533 Oren Jul 1997 A
5655520 Howe et al. Aug 1997 A
5655527 Scarberry et al. Aug 1997 A
5657493 Ferrero et al. Aug 1997 A
5657752 Landis et al. Aug 1997 A
5660174 Jacobelli Aug 1997 A
5662101 Ogden et al. Sep 1997 A
5666946 Langenback Sep 1997 A
5685296 Zdrojkowski et al. Nov 1997 A
5687715 Landis et al. Nov 1997 A
5715814 Ebers Feb 1998 A
5724965 Handke et al. Mar 1998 A
5746201 Kidd May 1998 A
5813423 Kirchgeorg Sep 1998 A
5832918 Pantino Nov 1998 A
5884624 Barnett et al. Mar 1999 A
5921239 McCall et al. Jul 1999 A
6082360 Rudolph et al. Jul 2000 A
6102040 Tayebi et al. Aug 2000 A
6112746 Kwok et al. Sep 2000 A
6119693 Kwok et al. Sep 2000 A
6357441 Kwok et al. Mar 2002 B1
6412487 Gunaratnam et al. Jul 2002 B1
6513526 Kwok et al. Feb 2003 B2
6581602 Kwok et al. Jun 2003 B2
6634358 Kwok et al. Oct 2003 B2
6701927 Kwok et al. Mar 2004 B2
6871649 Kwok et al. Mar 2005 B2
7007696 Palkon et al. Mar 2006 B2
7069933 Kwok et al. Jul 2006 B2
7178527 Kwok et al. Feb 2007 B2
8636006 Kwok et al. Jan 2014 B2
20020074001 Kwok et al. Jun 2002 A1
20060201515 Kwok et al. Sep 2006 A1
Foreign Referenced Citations (81)
Number Date Country
6405886 Apr 1987 AU
9177110 Nov 1991 AU
9464816 Dec 1994 AU
9516178 Jul 1995 AU
9459430 Feb 1996 AU
A 3291495 Feb 1996 AU
A 4101897 Apr 1998 AU
A 8931298 Jan 1999 AU
1039144 Sep 1928 CA
459104 Apr 1928 DE
701 690 Jan 1941 DE
159396 Jun 1981 DE
3015279 Oct 1981 DE
3345067 Jun 1984 DE
3537507 Apr 1987 DE
3539073 May 1987 DE
4004157 Apr 1991 DE
195 48 380 Dec 1994 DE
4343205 Jun 1995 DE
197 35 359 Jan 1998 DE
297 23 101 Jul 1998 DE
298 10846 Aug 1998 DE
0 054 154 Oct 1981 EP
0 252 052 Jul 1987 EP
0 264 772 Oct 1987 EP
0 303 090 Jul 1988 EP
0 386 605 Feb 1990 EP
0 462 701 May 1991 EP
0427474 May 1991 EP
0549 299 Jun 1993 EP
0 602 424 Nov 1993 EP
0 608 684 Aug 1994 EP
0 634 186 Jan 1995 EP
0 697 225 Jul 1995 EP
178 925 Apr 1996 EP
0 747 078 Dec 1996 EP
0 821 978 Feb 1998 EP
801629 Aug 1936 FR
858749 Dec 1940 FR
2 574 657 Jun 1986 FR
2 658 725 Aug 1991 FR
2 749 176 Dec 1997 FR
775911 May 1957 GB
848215 Sep 1960 GB
1395391 May 1975 GB
1 467 828 Mar 1977 GB
2005547 Apr 1979 GB
2145335 Mar 1985 GB
2147506 May 1985 GB
2 164 569 Mar 1986 GB
2211098 Jun 1989 GB
2 267 648 Dec 1993 GB
326983 Jun 1935 IT
44-16955 Jul 1969 JP
54-90892 Jul 1979 JP
09216240 Aug 1997 JP
WO 8001044 May 1980 WO
WO 8203548 Oct 1982 WO
WO 8606969 Dec 1986 WO
WO 8701950 Apr 1987 WO
WO 9103277 Mar 1991 WO
WO 9215353 Sep 1992 WO
WO 9220395 Nov 1992 WO
WO 9301854 Feb 1993 WO
WO 9402190 Feb 1994 WO
WO 9416759 Aug 1994 WO
WO 9419055 Sep 1994 WO
WO 9420051 Sep 1994 WO
WO 9502428 Jan 1995 WO
WO 9617643 Jun 1996 WO
WO 9625983 Aug 1996 WO
WO 9639206 Dec 1996 WO
WO 9707847 Mar 1997 WO
WO 9741911 Nov 1997 WO
WO 9804310 Feb 1998 WO
WO 9811930 Mar 1998 WO
WO 9818514 May 1998 WO
WO 9824499 Jun 1998 WO
WO 9826829 Jun 1998 WO
WO 9826830 Jun 1998 WO
WO 9848878 Nov 1998 WO
Non-Patent Literature Citations (32)
Entry
“ResMed Sullivan Mirage—The Mirage is Real—A Perfect Fit—First Time,” product brochure © ResMed Limited 1997, 4 pages.
Mirape Spare Parts Brochure, 1997, 2 pages.
Respironics, Inc. “Nasal Mask and Accessories Guide,” Dec. 23, 1991, 6 pages.
“InterVENTions, A Ventilatory Care Newsletter,” vol. 93, No. 1, Mar. 1993, Respironics, Inc., 16 pages.
“Order” from Respironics, Inc. v. ResCare Limited et al. case, Civil Action No. 95-151, with Exhibits E and G related to information allegedly available before Jul. 26, 1995, 20 pages.
Instructions for the Use for the Comfort Flap Small Child Contour Nasal Mask Accessory, Respironics Inc., Jul. 19, 1993, 2 pages.
“Comfort Flap™ Improves the Seal on Reusable Contour Nasal Masks,” InterVENTions, vol. 3, No. 1, Mar. 1993, 2 pages.
Mask 1 Photographs, Respironics Inc., Reusable Full Mask (small) Part # 452033 Lot #951108.
Mask 2 Photographs, Puritan—Bennett, Adam Curcuit , Shell Part # 231700, Swivel Part # 616329-00, Pillows (medium) Part #616324.
Mask 3, Photographs, DeVilbiss Healthcare Inc., DeVilbiss Seal-Ring and CPAP Mask Kit (medium), Part 73510-669.
Mask 4 Photographs, Respironics Inc., Monarch Mini Mask with Pressure Port, Part # 572004, Monarch Headgear, Part # 572011.
Mask 5 Photographs, Healthdyne Technologies, Nasal CPAP Mask (medium narrow), Part # 702510.
Mask 6 Photographs, Healthdyne Technologies, Soft Series Nasal CPAP Mask, Part # 702020.
Mask 7 Photographs, DeVilbiss Heath-scare Inc., Small Mask and Seat Rings, Part # 73510-668.
Mask 8 Photographs, Respironics Inc., Reusable Contour Mask (medium), Part # 302180-.
Mask 9 Photographs, Healthdyne Technologies, Healthdyne Large Headgear.
Mask 10 Photographs, Respironics Inc., Soft Cap (medium), Part # 302142.
Mask 11 Photographs, Weinmann: Hamburg, Nasalmaskensystem mit Schalldämpfer (medium), Part # WN 23105.
Mask 12 Photographs, Life Care.
Mask 13 Photographs, Healthdyne Technologies.
Mask 14 Photograph, King System.
Mask 15 Photographs, Respironics Inc., Paediatric Mask.
Mask 16 Photographs, Hans Rudolph Inc., Hans Rudolph Silicone Rubber Face Mask/8900.
Decision on Appeal completed on Mar. 25, 2008 for corresponding Japanese Application No. 2005-23339, 21 pages.
Office Action issued in related U.S. Appl. No. 11/826,267 dated Oct. 17, 2010.
Notice of Opposition for corresponding European Application No. 06115004.1, dated Feb. 9, 2012, 27 pages.
EP Communication issued in corresponding European Application No. 10 183 685.6, dated Apr. 2, 2014, 3 pages.
EP Communication issued in corresponding European Application No. 10 184 794.5, dated Apr. 2, 2014, 4 pages.
Interlocutory Decision in Opposition Proceedings mailed Mar. 11, 2015 in European Application No. 06 115 004.1 (EP Pat. No. 1 741 461), 24 pages.
Minutes of the Oral Proceeding mailed Mar. 11, 2015 in European Application No. 06 115 004.1 (EP Pat. No. 1 741 461), 12 pages.
U.S. Office Action mailed Feb. 19, 2016 in U.S. Appl. No. 14/012,483 (26 pages).
Extended European Search Report mailed Feb. 25, 2016 in European Application No. 15181229.4 (6 pages).
Related Publications (1)
Number Date Country
20140137871 A1 May 2014 US
Continuations (3)
Number Date Country
Parent 11648537 Jan 2007 US
Child 14163945 US
Parent 10068963 Feb 2002 US
Child 11648537 US
Parent 09230491 US
Child 10068963 US